摘要
The treatment of infants with established bronchopulmonary dysplasia (BPD) remains a common,frustrating and expensive problem in neonatology, pediatric PlUlmonology, pediatric critical care and general pediatrics.
The treatment of infants with established bronchopulmonary dysplasia (BPD) remains a common,frustrating and expensive problem in neonatology, pediatric PlUlmonology, pediatric critical care and general pediatrics.